Alain Xicluna
- Organic Chemistry top 10%
- Synthesis and biological activity 11
- Synthesis and Biological Evaluation 6
- Multicomponent Synthesis of Heterocycles 4
- Toxicology top 10%
- Pharmacology top 10%
- Synthesis of Organic Compounds 12
-
- Analytical Chemistry and Chromatography 8
-
- Protein purification and stability 5
- Protein Interaction Studies and Fluorescence Analysis 4
-
- Estrogen and related hormone effects 6
Alain Xicluna
34 papers receiving 373 citations
Peers
Comparison fields: 5 of 61
- Organic Chemistry 255
- Toxicology 25
- Pharmacology 91
- Spectroscopy 37
- Molecular Biology 128
Countries citing papers authored by Alain Xicluna
This map shows the geographic impact of Alain Xicluna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Xicluna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Xicluna more than expected).
Fields of papers citing papers by Alain Xicluna
This network shows the impact of papers produced by Alain Xicluna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Xicluna. The network helps show where Alain Xicluna may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alain Xicluna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 13 | |
| 2 | 2007 | 39 | |
| 3 | 2007 | 70 | |
| 4 | 2007 | 13 | |
| 5 | 2005 | 23 | |
| 6 | 2005 | 1 | |
| 7 | 2004 | 46 | |
| 8 | 2004 | 8 | |
| 9 | 2003 | 29 | |
| 10 | 2003 | 5 | |
| 11 | 2003 | 6 | |
| 12 | 2003 | 2 | |
| 13 | 2002 | 6 | |
| 14 | 2002 | 11 | |
| 15 | 2001 | 37 | |
| 16 | 2001 | 2 | |
| 17 | [Relation of conformation and antalgic activity of 2-aryl-dihydrothienocoumarins]. | 1988 | 3 |
| 18 | [Preparation and pharmacologic approach of a series of dihydro-4,5 thieno(2,3-c)quinoline-4-ones]. | 1988 | 3 |
| 19 | [Preparation, spectral studies (IR, NMR) and pharmacologic approach to a series of 2-arylthieno(2,3-c)benzo(e)pyran-4-ones]. | 1986 | 3 |
| 20 | 1984 | 3 |
About Alain Xicluna
Alain Xicluna is a scholar working on Pharmacology, Organic Chemistry and Spectroscopy, having authored 34 papers that have together received 393 indexed citations. Recurring topics across this work include Synthesis of Organic Compounds (12 papers), Synthesis and biological activity (11 papers), Analytical Chemistry and Chromatography (8 papers), Estrogen and related hormone effects (6 papers), Synthesis and Biological Evaluation (6 papers), Protein purification and stability (5 papers), Multicomponent Synthesis of Heterocycles (4 papers) and Protein Interaction Studies and Fluorescence Analysis (4 papers). The work is most often cited by research in Organic Chemistry (255 citations), Toxicology (25 citations) and Pharmacology (91 citations). Alain Xicluna has collaborated with scholars based in France and Belgium. Frequent co-authors include Bernard Refouvelet, Yves Jacquot, Laurent Nicod, Yves Claude Guillaume, Guy Leclercq, Catherine Guyon, Lhassane Ismaïli, Claire André, Laurent Bermont and J. F. Robert. Their work appears in journals such as Analytical Chemistry, European Journal of Medicinal Chemistry and Talanta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.